January 6, 2022
Now available UNBRANDED Infliximab
Infliximab is indicated for the treatment of:
- Crohn’s Disease
- Pediatric Crohn’s Disease- Ulcerative Colitis
- Pediatric Ulcerative Colitis
- Rheumatoid Arthritis in combination with methotrexate
- Ankylosing Spondylitis
- Psoriatic Arthritis
- Plaque Psoriasis